• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Johns Hopkins Arthritis Center

Show Search
Hide Search
  • Disease Information
    • Rheumatoid Arthritis
    • Psoriatic Arthritis
    • Ankylosing Spondylitis
    • Osteoarthritis
    • Gout
    • Osteoporosis
  • Patient Corner
    • Drug Information Sheets
    • Managing Your Arthritis
    • RheumTV – Patient Education Video Library
  • Our Research
    • Patient-Centered Outcomes Research
    • Current Research Studies
    • The Camille Julia Morgan Arthritis Research and Education Fund
  • About Us
    • Appointment Information
    • Contact Us
    • Our Faculty
    • Our Staff
    • Rheumatology Specialty Centers
  • Donate
Home / Ask the Expert / Remicade Treatment

Remicade Treatment

April 5, 2007 By Arthritis Center

Question

I need to ask a question concerning the Remicade treatment for Rheumatoid Arthritis. My sister is trying the Remicade for the second go round. The first time see only made it thru three treatment sessions because she experienced some breathing problems. Her new doctor has recommended that she try it again and this time she experienced breathing problems again on the second treatment. What are the side effects of this treatment? Her doctor still wants her to continue taking the treatments and now she is fearful to continue. I am a little skeptical about this treatment because it appears to be putting my sister at risk. The treatments are done in a doctors office and no one was in the room with her when she was experiencing problems. Is this a normal problem with the treatment. How can I get more information on this treatment?

Answer

Look on this website for additional information. Remicade is a monoclonal antibody that specifically binds TNF and neutralizes it. TNF is a protein that is found in high amounts in patients with rheumatoid arthritis and other inflammatory disease. Remicade is given by IV infusion, usually in a doctor’s office. In general, Remicade is well tolerated. Occasionally, patients will experience an infusion reaction. This reaction can consist of one or more of the following: hives, itching, flushing of the face, heart palpitations, shortness of breath or fever. The reactions are most common in the first few infusions and often can be prevented by slowing down the infusion or pretreatment with tylenol or antihistamines. Infusion nurse are trained to deal with these reactions. Other possible side effects are an increased risk of infection similar to the other anti-TNF drugs, Enbrel and Humira.

Arthritis Center

Founded in 1998, the Arthritis Center at Johns Hopkins is dedicated to providing quality education to patients and healthcare providers alike.

Primary Sidebar

Ask The Expert Topics

  • Alternative Therapies
  • Ankylosing Spondylitis
  • Associated With Other Illnesses
  • Bursitis and Tendinitis
  • Corticosteroids
  • Diet and Exercise
  • Disease Modifying Antirheumatic Drugs (DMARDs)
  • Enteropathic Arthritis
  • Fibromyalgia
  • General Arthritis
  • Gout, Pseudogout, Other
  • Infectious Arthritis
  • Myositis
  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
  • Osteoarthritis
  • Osteonecrosis
  • Osteoporosis
  • Polymyalgia Rheumatica
  • Psoriatic Arthritis
  • Reactive Arthritis
  • Regional Pain: Back and Neck
  • Rehabilitation
  • Rheumatoid Arthritis
  • Surgical Therapy
  • Systemic Lupus Erythematosus (SLE)
  • Systemic Sclerosis
  • Vasculitis
RheumTV Logo

Rheum.TV is an informational platform created to educate patients living with a rheumatic disease. With over 100 disease education videos produced by the team at Johns Hopkins Rheumatology.

Visit Rheum.TV

Footer

Johns Hopkins Rheumatology

  • Johns Hopkins Rheumatology
  • Johns Hopkins Lupus Center
  • Johns Hopkins Lyme Disease Research Center
  • Johns Hopkins Myositis Center
  • Johns Hopkins Scleroderma Center
  • Johns Hopkins Sjögren’s Syndrome Center
  • Johns Hopkins Vasculitis Center

Connect With Us

  • Facebook
  • Twitter
  • YouTube

Johns Hopkins Medicine

© 2023 Johns Hopkins Arthritis Center
Patient Privacy